St. Francis Hospital Nsambya, commonly known as Nsambya Hospital, is a hospital in Kampala, the capital of Uganda and the largest city in that country.

During the past decade, St. Francis Hospital, Nsambya conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Francis Hospital, Nsambya" #1 sponsor was "Case Western Reserve University" with 1 trials, followed by "Dr Andrew Odur" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "The Hospital for Sick Children" with 1 trials sponsored and "University of Minnesota" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Francis Hospital, Nsambya" #1 collaborator was "Fogarty International Center of the National Institute of Health" with 1 trials as a collaborator, "International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "St. Francis Hospital, Nsambya" are "COVID" (1 trials), "Covid19" (1 trials), "Early Breast Cancer" (1 trials), "Neonatal Death" (1 trials) and "Perinatal Death" (1 trials). Many other conditions were trialed in "St. Francis Hospital, Nsambya" in a lesser frequency.

Most popular intervention types in "St. Francis Hospital, Nsambya" are "Other" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ETAU" (1 trials), "Endocrine Therapy of Physician's Choice" (1 trials), "Fetal heart rate Doppler" (1 trials), "Giredestrant" (1 trials) and "Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Francis Hospital, Nsambya" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "St. Francis Hospital, Nsambya". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in St. Francis Hospital, Nsambya, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Francis Hospital, Nsambya, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".